Related Experiment Video

Updated: Sep 16, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

859

ASO Author Reflections: From Risk to Strategy-Personalizing Gastric Cancer Surveillance in Lynch Syndrome

Daniela Carvalho da Silva1, Fabiana Sousa2,3,4, Ana Silva3

  • 1Faculty of Medicine, University of Porto, Porto, Portugal. dani.jcsilva093@gmail.com.

Annals of Surgical Oncology
|July 9, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
05:16

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors

Published on: February 19, 2022

6.1K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.2K

Related Experiment Videos

Last Updated: Sep 16, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

859
Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
05:16

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors

Published on: February 19, 2022

6.1K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.2K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

Articles linked to this work by shared authors, journal, and citation graph.

Self-reported food allergy in the elderly - Lifetime prevalence and clinical features in older adults seeking allergy care in Brazil.

The World Allergy Organization journal·2026

Comparison between as-needed versus regular treatment for allergic rhinitis: Protocol for a systematic review.

Allergologie select·2026

Genetic risk factors in Early-Onset Gastric Cancer: A systematic review and meta-analysis.

Cancer genetics·2026

Mapping medication adherence tools in Africa: a scoping review.

BMJ open·2026

Planetary Health in Health Guidelines: Expert Workshop Report 2024.

Clinical and public health guidelines·2026

Comparison between two tools assessing the methodological quality of systematic reviews: ReMarQ and AMSTAR 2.

Clinical and public health guidelines·2026

Neoadjuvant Chemo-Immunotherapy Yields Survival Comparable to Upfront Surgery in Metaplastic Breast Cancer: A National Cancer Database Analysis.

Annals of surgical oncology·2026

The Use and Utility of Preoperative Somatostatin Receptor-Based Imaging in Gastroenteropancreatic Neuroendocrine Tumors.

Annals of surgical oncology·2026

Impact of Machine Perfusion on Liver Transplantation for Hepatocellular Carcinoma.

Annals of surgical oncology·2026

Prefoldin Subunit 2 Promotes Migration of Hepatocellular Carcinoma Cells and Is Associated with Poor Prognosis.

Annals of surgical oncology·2026

Quantitative CT-Derived Imaging Features Improve Preoperative Risk Stratification of Intraductal Papillary Mucinous Neoplasms.

Annals of surgical oncology·2026

Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adenocarcinoma (PDAC).

Annals of surgical oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us